GSK
Prescription Drugs · Vaccines

GSK revenue, results and funding

GSK filed revenue of £32.7B for 2025.

Data updated Nov 20, 2026 · Back to the company report
£32.7BRevenue, 2025
£5.7BNet income, 2025
99,300Employees, 2016
GSKLondon Stock Exchange

Results by year

YearRevenueNet incomeTotal assetsEmployeesLANG_CR_S_M_TAX_PAIDLANG_CR_S_M_TAX_EXPENSELANG_CR_S_M_DIVIDENDSLANG_CR_S_M_BUYBACKSLANG_CR_S_M_CAPEXLANG_CR_S_M_STAFF_COSTSLANG_CR_S_M_SBCLANG_CR_S_M_RNDLANG_CR_S_M_OPERATING_INCOMELANG_CR_S_M_CASHLANG_CR_S_M_DEBTLANG_CR_S_M_ACQUISITIONS
2025£32.7B£5.7B£61.1B–£1.2B£1.1B£2.6B£1.4B£1.3B£8.8B£390M£7.5B£7.9B£3.4B£14.7B£1.7B
2024£31.4B£2.6B£59.5B–£1.3B£526M£2.4B£0£1.4B£8.8B£347M£6.4B£4B£3.9B£14.6B£805M
2023£30.3B£4.9B£59B–£1.3B£756M£2.2B£0£1.3B£8.5B£321M£6.2B£6.7B£2.9B£15.2B£1.5B
2022£29.3B£15B£60.1B–£1.3B£707M£3.5B–£1.1B£7.7B£314M£5.5B£6.4B£3.7B£17B£3.1B
2021£24.7B£4.4B£79.1B–£1.3B£83M£4B–£950M£7.7B£345M£5B£4.4B£4.3B£20.6B£0
2020£24.4B£5.7B£80.4B–£1.7B£67M£4B–£989M£8.6B£330M£4.8B£6B£6.3B£23.4B£0
2019£33.8B£4.6B£79.7B–£1.5B£953M£4B–£1.3B£9.9B£432M£4.6B£7B£4.7B£23.6B£3.6B
2018£30.8B£3.6B£58.1B–£1.3B£754M£3.9B–£1.3B£9.4B£393M£3.9B£5.5B£3.9B£20.3B£0
2017£30.2B£1.5B£56.4B–£1.3B£1.4B−£3.9B–£1.5B£9.1B£347M£4.5B£4.1B£3.8B£14.3B–
2016£27.9B£912M£59.1B99,300£1.6B£877M£4.9B–£1.5B£8.2B£338M£3.6B£2.6B£4.9B£14.7B−£17M
2015£23.9B£8.4B––£2.1B£2.2B£3.9B–£1.4B£8B£349M£3.6B£10.3B£5.8B–£3.2B
2013–––99,541––––––––––––
Sources: SEC, Wikidata

How to cite

GSK, Financials. Alion, Nov 20, 2026. https://alion.io/company/gsk/financials

.json · .md · CC BY-SA 4.0